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ShiveringAbstract Remifentanil based anesthesia was found to be associated with high incidence of postop-
erative shivering. This study was designed to evaluate the effect of preoperative administration of
IV parecoxib sodium (a selective COX 2 inhibitor) on remifentanil induced shivering during the ﬁrst
2 h following surgery.
Method: In a randomized, placebo-controlled, double blind study, sixty-seven patients with ASA
physical status I, aged 20–60 years underwent elective lumber discectomy, were randomly allocated
to receive either parecoxib sodium 40 mg IV (group P, n= 33) or saline IV (group S, n= 34)
30 min before induction of anesthesia which was induced with remifentanil 0.5 ug/kg/min, propofol,
and cisatracurium and was maintained with remifentanil 0.1–0.3 ug/kg/min, sevoﬂurane, O2/N2O
and cisatracurium. The incidence and grades of postoperative shivering were evaluated for 2 h.
Results: The incidence of postoperative shivering was 36% in parecoxib group which was signiﬁ-
cantly less than that of saline group 64% (p< 0.05). Number of patients who developed grade 3
shivering, number of patients received meperidine to treat shivering and postoperative morphine
requirement were signiﬁcantly less in group P than that of group S (p< 0.05).
Conclusion: Administration of parecoxib sodium 40 mg IV 30 min before induction of general
anesthesia signiﬁcantly reduced the incidence and severity of remifentanil induced shivering
compared to placebo in patients underwent elective lumber discectomy under general anesthesia.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.D license.1. Introduction
Shivering is a frequent postoperative complication of general
anesthesia [1]. Shivering causes patient discomfort, interrup-tion of monitoring, increases O2 consumption, CO2 produc-
tion, and catecholamine secretion that increase cardiac
output, heart rate, and blood pressure [2].
Remifentanil, an ultra-short-acting l opioid receptor ago-
nist, is widely used intraoperatively to provide good intraoper-
ative analgesia and stable intraoperative hemodynamics.
However, a number of studies reported an increase in the
incidence of postoperative shivering with remifentanil [3–5]
and it is more likely to occur with remifentanil than other
opioids [6].
400 A.A. Elmawgood et al.A wide range of drugs have been reported to be effective in
suppressing shivering including meperidine; tramadol; keta-
mine; ondansetron; clonidine and midazolam [7].
Parecoxib is a prodrug of valdecoxib, a selective cyclooxy-
genase 2 inhibitor (COX 2 inhibitor), has been found to be
effective in reduction of the remifentanil induced hyperalgesia
[8,9] and some studies suggested a relationship between remif-
entanil induced hyperalgesia and postoperative shivering with
activation of N-methyl-D-aspartate (NMDA) receptors [4,10].
Therefore, we hypothesized that preoperative administration
of parecoxib sodium may prevent the development of remifen-
tanil-induced shivering during the ﬁrst postoperative 2-h. So,
in this randomized, placebo-controlled, double-blind study
we evaluated the effects of preoperative intravenous parecoxib
sodium given 30 min before induction of anesthesia on postop-
erative shivering after remifentanil-based general anesthesia2. Method
After approval of the local ethical committee, a written
informed consents were obtained from 70 patients with Amer-
ican Society of Anesthesiology (ASA) physical status I aged
20–60 years old, planned for lumbar discectomy under general
anesthesia in Dar Alshifa hospital (State of Kuwait) from
August 2013 to April 2014
Patients were excluded from the study if there was any con-
traindication to parecoxib (cardiovascular disease, peripheral
arterial disease, cerebrovascular disease, peptic ulcer, Inﬂam-
matory bowel disease, bronchial asthma, hepatic or renal dis-
ease), those with history of thyroid dysfunction, known allergy
to the study drug or other nonsteroidal anti-inﬂammatory
drugs (NSAID), an initial body temperature >38 C or
<36 C, BMI > 30 kg/m2 or who required blood transfusion.
All patients were premedicated with omeprazole 40 mg iv,
primperane 10 mg iv and midazolam 5 mg oral 1 h before
surgery.
When patients arrived to the operation theater, they were
randomly assigned to one of two equally divided groups (35
patients each) by using the closed envelop technique. Parecox-
ib group (group P) received parecoxib 40 mg iv (Dynastate,
Pﬁzer Manufacturing, Puurs, Belgium) and saline group
(group S) received the same volume of saline, and the studied
drugs were prepared in 2 ml syringe by an anesthesia nurse
unaware of the study as per the envelope and were given to
the patients in the anesthesia preparation room 30 min before
induction of anesthesia.
The operating room temperature was adjusted at 22 C.
The patients were shifted to the operating room where they
were monitored with electrocardiogram (ECG), non-invasive
arterial blood pressure, pulse oximetry (Spo2), and capnogra-
phy (after intubation).
General anesthesia was induced with remifentanil 0.5 lg/
kg/min for 1 min using syringe pump (Alaris, Cardinal
Health, Switzerland) followed by propofol 1–2 mg/kg and
cisatracurium 0.15 mg/kg, and then the patients were
intubated with armored cuffed endotracheal tube and mechan-
ically ventilated. After induction, patients were put in prone
position with proper padding of the pressure points with gel
pads. The anesthesia was maintained by sevoﬂurane 1–
1.5 vol%, O2/N2O (50/50%), remifentanil 0.1–0.3 lg/kg/minand cisatracurium 0.03 mg/kg guided by peripheral nerve
stimulator.
All through the anesthesia time, the patients were actively
warmed by lower body forced air warming device (Bair Hug-
ger_warming unit, Arizant Healthcare Inc., USA) and warm
iv ﬂuids using level 1 hot ﬂuid warmer (Rockland, MA,
USA) to maintain core temperature above 35.5 C.
At the end of the procedure, the surgical wound was
inﬁltrated with 20 ml of bupivacaine 0.5% by the surgeon
taking all layers including the muscle layer with iv infusion
of paracetamol 1 g (perfalgan, Bristol-Myers Squibb, Ana-
gni, Italy).
At the end of the operation the patients were returned to
supine position, and remifentanil and sevoﬂurane were
stopped with reversal of residual neuromuscular blockade
(neostigmine 0.05 mg/kg and atropine 0.02 mg/kg); the
patients were extubated and were shifted to postanesthesia
care unit (PACU) where they were monitored and observed
for 2 h.
In PACU the ambient temperature was adjusted at 25 C,
O2 face mask and whole body forced air warming device was
applied and the patients complained of pain were treated by
IV morphine boluses (2 mg) that repeated every 15 min until
patients became pain free.
The following parameters were evaluated in all patients by
an anesthesia technician unaware of the study drugs:
(1) Core temperature (tympanic membrane temperature
using FirstTemp Genius Model 3000, Sherwood Medi-
cal Company, St. Louis, UK) before induction of anes-
thesia, 1 h after induction of anesthesia, after extubation
and in PACU every 30 min for 2 h.
(2) Shivering intensity was graded by using a ﬁve-point scale
that was used in the study of Nakasuji and colleagues
(4):
Grade 0: none;
Grade 1: one or more areas of piloerection but without vis-
ible muscular activity;
Grade 2: visible muscular activity conﬁned to one muscle
group;
Grade 3: same as Grade 2 but in more than one muscle
group;
Grade 4: gross muscular activity involving the entire body).
Shivering grades 3 and 4 were considered postoperative
shivering and treated with iv meperidine 20 mg.
(3) The incidence of shivering.
(4) Number of patients requiring meperidine.
(5) Time to ﬁrst postoperative analgesic requirement.
(6) Postoperative morphine consumption in the ﬁrst 2 h
after surgery.
(7) Postoperative side effects such as– Nausea and vomiting (treated with metoclopramide
10 mg iv).
– Sedation (graded on a ﬁve-point scale: 1: fully a-
wake and oriented; 2: drowsy; 3: eyes closed, aro-
usable to command; 4: eyes closed, arousable to
physical stimulation; and 5: eyes closed, unrousable
to physical stimulation) [11].
Table 2 Incidence and severity of shivering and number of
patients received meperidine.
Variables Group
S (n= 34)
Group
P (n= 33)
Total number of shivering patients 22(64) 12(36)*
Grades of shivering
Grade 0 12(35) 21(64)*
Grade 1 3(9) 2(6)
Grade 2 2(5) 2(6)
Grade 3 17(50) 8(24)*
Grade 4 0(0) 0(0)
Number of patients received meperidine 17(50) 8(24)*
Group S: saline group, group P: parecoxib group.
Data presented as number (%).
* Signiﬁcant difference (p< 0.05) compared to group S.
Table 3 Core temperature (tympanic membrane temperature).
Time Group S (n= 34) Group P (n= 33)
Before induction 36.6(0.1) 36.7(0.2)
1 h After induction 36.5(0.2) 36.4(0.1)
After extubation 36.3(0.2) 36.4(0.2)
PACU 0 min 36.2(0.1) 36.3(0.2)
PACU 30 min 36.2(0.1) 36.1(0.1)
PACU 60 min 36.1(0.2) 36.1(0.1)
PACU 90 min 35.9(0.2) 36(0.2)
PACU 120 min 35.9(0.1) 35.8(0.2)
Group S: saline group, group P: parecoxib group, PACU 0:
admission to PACU, PACU 30: 30 min in PACU, PACU 60:
60 min in PACU, PACU 90: 90 min in PACU, PACU 120: 120 min
in PACU.
Data presented as mean (SD).
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Based on the incidence of postanaesthetic shivering with rem-
ifentanil from the previous study [4] was 60%, The sample size
required to achieve 50% reduction was minimum 33 patients
in each group with a power of 80% and an a of 0.05.
Data values were presented as means (SD), or number (%).
Numerical data were analyzed by using Student’s unpaired
t-test. Nonparametric data were analyzed by using the Mann
Whitney U-test. A value of P< 0.05 was considered signiﬁ-
cant. All statistical calculations were done using computer
programs Microsoft Excel version 7 (Microsoft Corporation,
NY, USA).
4. Results
Seventy patients were included in this study; however, two
patients in parecoxib group and one patient in saline group
were excluded from the study because they received blood
transfusion.
The two groups were comparable regarding the age, weight,
Sex, and duration of operation (Table 1).
The incidence of shivering was signiﬁcantly reduced in
parecoxib group being 36% compared to saline group being
64% (p< 0.05). Grade 3 shivering was signiﬁcantly low in
group P compared to group S (p< 0.05). There was no signif-
icant difference between groups in grades of shivering 1, 2 and
4. Patients who received meperidine were signiﬁcantly low in
group P compared to group S (p< 0.05) (Table 2).
Core temperature was comparable between the two groups
at different times of measurement intraoperative and in PACU
(p> 0.05) (Table 3).
The time to ﬁrst postoperative analgesic requirement and
morphine consumption during the ﬁrst 2 h after surgery were
signiﬁcantly less in parecoxib group compared to saline group
(Table 4).
The incidence of nausea, vomiting, and sedation were com-
parable in patients of the two groups (p> 0.05) (Table 5).
5. Discussion
This study showed that parecoxib treated patients shivered less
than the patients in the saline group with lower grades of shiv-
ering and less number of patients received meperidine to stop
shivering compared to those of the saline group.
Remifentanil based anesthesia is commonly used intraoper-
atively because of its ultrashort acting effect that can be
rapidly titrated to provide hemodynamic stability and rapid
recovery, however postoperative shivering is common afterTable 1 Demographic data and operation time.
Variables Group S (n= 34) Group P (n= 33)
Age 38.7(5.8) 41.3(7.5)
Weight (kg) 83.3(6.7) 85.2(6.2)
Sex (M/F) 25/9 22/11
Operation time (min) 111.8(10.7) 115.5(13.9)
Group S: saline group, group P: parecoxib group.
Data presented as mean (SD) or number.remifentanil discontinuation, but the exact underlying mecha-
nism is unclear. Therefore, there are many theories tried to
explain postoperative shivering after remifentanil infusion;
The ﬁrst theory is intraoperative hypothermia which was
prevented in this study by active warming of the patients intra-
operatively and in PACU with no difference between groups in
core temperature, and this is in agreement with the study of
Nakasuji et al. who conclude that remifentanil induced shiver-
ing is not related to intraoperative hypothermia [4].
The second theory is pain which is prevented in this study
by intraoperative infusion of paracetamol and wound inﬁltra-
tion with local anesthetic and iv morphine titration postoper-
atively, and this is in line with the study of Nakasuji et al.
[4] who suggested that shivering is not related to pain because
in this study pain was relieved with epidural analgesia and the
study of Heid and colleagues who found that intraoperative
tramadol decreased the incidence of postoperative shivering
without changing postoperative pain under general anesthesia
[12].
The third theory, which is the more likely underlying the-
ory, is that remifentanil induced shivering is related to the rem-
ifentanil induced hyperalgesia and it is a sign of opioid induced
hyperalgesia with suspected activation of the N-methyl-D-
aspartate (NMDA) receptors as it was found that NMDA
application in the preoptic anterior hypothalamus (central
Table 4 Time to ﬁrst postoperative analgesic requirement and morphine consumption during the ﬁrst 2 h after surgery.
Variables Group S (n= 34) Group P (n= 33)
Time to ﬁrst postoperative analgesic requirement (min) 7.3(0.9) 10.7(1.1)*
Morphine consumption during the ﬁrst 2 h after surgery (mg) 6.1(1.1) 3.6(0.9)*
Group S: saline group, group P: parecoxib group,
Data presented as mean (SD).
* Signiﬁcant difference (p< 0.05) compared to group S.
Table 5 Incidence of side effects.
Variables Group S (n= 34) Group P (n= 33)
Nausea 6(17) 4(12)
Vomiting 1(2.9) 1(3)
Sedation 20(59) 15(45)
Group S: saline group, group P: parecoxib group.
Data presented as number (%).
402 A.A. Elmawgood et al.control of shivering) increases ﬁring of neurons in rats [13].
This theory was supported by the observation of the previous
studies of Ro¨hm et al. [5], Zhao and Joo [10], and Song et al.
[13], also both shivering and hyperalgesia could be reduced by
NMDA antagonists such as low dose ketamine 0.25 mg/kg iv
just before skin incision, followed by 5 lg/kg/min iv until skin
closure in the study of Masato et al. [14] and magnesium sul-
fate 50 mg kg(1) iv followed by 15 mg kg(1) h(1) iv in
the study of Ryu et al. [15].
Published Ahead-of-To our knowledge, there were no stud-
ies reported the effect of parecoxib on remifentanil induced
shivering. The results of this study coincided with the result
of Xiuze et al. that showed that iv parecoxib 40 mg before
the end of surgery decreased the incidence and severity of post-
operative shivering after general anesthesia [16]. Also, the
study of Tro¨ster et al. [17] showed that parecoxib administra-
tion before remifentanil infusion potentiates the analgesic
effect of remifentanil and reduced remifentanil hyperalgesia
which is in line with our result of increased time to ﬁrst post-
operative analgesic requirement and reduced postoperative
morphine consumption. The parecoxib exerts these effects
through inhibition of cyclo-oxygenase and prevention of pros-
taglandins production, and it was found that prostaglandins
especially prostaglandin E2 stimulate release of glutamate in
spinal cord dorsal horns [18] and the prostaglandins depolarize
the deep spinal cord dorsal horn neurons and disinhibit the
glycinergic neurotransmission in the superﬁcial layers of spinal
cord dorsal horn neurons causing sensitization of the spinal
nociceptive system with activation of the NMDA receptors
[19].
In this study parecoxib was given 30 min before induction
of anesthesia instead of given 30 min before end of surgery
in the study of Xiuze et al. [16] and we found that parecoxib
treated patients showed less postoperative morphine consump-
tion and longer time to ﬁrst postoperative analgesic require-
ment compared to control group as it was found that early
administration of iv parecoxib 30 min before starting remifen-
tanil infusion was effective in reducing remifentanil induced
hyperalgesia, while parallel administration was ineffective [17].Morphine was used to treat postoperative pain; it was
found that morphine does not have effect on postoperative
shivering [20] and the results of the present study showed that
patients received meperidine to control shivering; received less
doses of morphine than other patients and the sedation was
reported after injection of morphine and meperidine.
The incidence of nausea and vomiting was found unexpect-
edly comparable in patients of both groups; in spite of using
morphine and meperidine more in saline group, as parecoxib
causes nausea and vomiting.
We concluded that intravenous parecoxib sodium 40 mg
administrated 30 min before induction of anesthesia effectively
reduced the incidence and severity of remifentanil induced
shivering compared to placebo in patients undergoing lumbar
discectomy under general anesthesia.Conﬂict of interest
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